Table of Contents Author Guidelines Submit a Manuscript
Canadian Respiratory Journal
Volume 10, Issue 7, Pages 381-388
http://dx.doi.org/10.1155/2003/453183
Original Article

A Case for Rimantadine to Be Marketed in Canada for Prophylaxis of Influenza a Virus Infection

Fawziah Marra,1 Carlo A Marra,2 and H Grant Stiver3

1Faculty of Pharmaceutical Sciences, University of British Columbia, and British Columbia Centre for Disease Control, Canada
2Faculty of Pharmaceutical Sciences, University of British Columbia, and Centre for Health Evaluation and Outcomes Sciences, St Paul’s Hospital, Department of Health Care and Epidemiology, Faculty of Medicine, Canada
3Faculty of Medicine, University of British Columbia, and Division of Infectious Diseases, Department of Medicine, Vancouver Hospital and Health Sciences Centre, Vancouver, British Columbia, Canada

Copyright © 2003 Hindawi Publishing Corporation. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to Cite this Article

Fawziah Marra, Carlo A Marra, and H Grant Stiver, “A Case for Rimantadine to Be Marketed in Canada for Prophylaxis of Influenza a Virus Infection,” Canadian Respiratory Journal, vol. 10, no. 7, pp. 381-388, 2003. https://doi.org/10.1155/2003/453183.